Development stage
2
Assets whose furthest-along trial is at this stage.
(Z)-endoxifen
Small moleculePhase 2
177Lu-BetaBart
RadiopharmaceuticalPhase 2
177Lu-DPI-4452
RadiopharmaceuticalPhase 2
2-hydroxybenzylamine acetate
Small moleculePhase 2
3BNC117
Monoclonal antibodyPhase 2
50561
Small moleculePhase 2
7MW3711
Small moleculePhase 2
9MW1911
Monoclonal antibodyPhase 2
A2B395
Cell therapyPhase 2
A2B530
Cell therapyPhase 2
A2B543
Cell therapyPhase 2
A2B694
Cell therapyPhase 2
AADvac1
VaccinePhase 2
AAV1.SERCA2a
Gene therapy / editingPhase 2
AB-1002
Gene therapy / editingPhase 2
AB-1005
Gene therapy / editingPhase 2
AB8939
Unknown / undisclosedPhase 2
ABBV-1758
Monoclonal antibodyPhase 2
ABBV-2001
Multispecific antibodyPhase 2
ABBV-295
PeptidePhase 2
ABBV-6628
Antibody fragmentPhase 2
ABD-3001
Unknown / undisclosedPhase 2
ABP-671
Small moleculePhase 2
ABP-745
Small moleculePhase 2
ABS-1230
Small moleculePhase 2
ABSK043
Monoclonal antibodyPhase 2
ABSK061
Small moleculePhase 2
ABT-101
Small moleculePhase 2
AC-101
Small moleculePhase 2
AC01
Small moleculePhase 2
ACC017
Small moleculePhase 2
ACI-24.060
VaccinePhase 2
ACP-01
Unknown / undisclosedPhase 2No recent activity
ACP-211
Small moleculePhase 2
AD04
Biologic — subtype unspecifiedPhase 2
ADR-002K
Cell therapyPhase 2
AFFITOPE PD01A / ACI-7104.056
Biologic — subtype unspecifiedPhase 2
AFNT-211
Small moleculePhase 2
AGuIX
Small moleculePhase 2
AK117
Unknown / undisclosedPhase 2
AK129
Multispecific antibodyPhase 2
AK138D1
Small moleculePhase 2
AK139
Multispecific antibodyPhase 2
AK146D1
Antibody–drug conjugatePhase 2
AL8326
Small moleculePhase 2
ALE.P02
Antibody–drug conjugatePhase 2
ALE.P03
Antibody–drug conjugatePhase 2
ALK202
Small moleculePhase 2
ALN-ANG3
RNA / oligonucleotidePhase 2
ALN-CIDEB
Unknown / undisclosedPhase 2
ALN-HSD
Unknown / undisclosedPhase 2
ALN-PNP
Unknown / undisclosedPhase 2
ALN-SOD
Unknown / undisclosedPhase 2
ALTB-268
Monoclonal antibodyPhase 2
ALTO-100
Small moleculePhase 2
ALTO-101
Small moleculePhase 2
ALTO-203
Small moleculePhase 2
ALTO-207
Small moleculePhase 2
ALTO-300
Small moleculePhase 2
AMT-260
Gene therapy / editingPhase 2
ANAVEX3-71
Small moleculePhase 2
ANS02
Small moleculePhase 2
AP-472
Small moleculePhase 2
AP203
Small moleculePhase 2
APG-115
Unknown / undisclosedPhase 2
APL-9796
Monoclonal antibodyPhase 2
APX-115
Small moleculePhase 2No recent activity
ARD103
Unknown / undisclosedPhase 2
ARO-ALK7
RNA / oligonucleotidePhase 2
ARO-DIMER-PA
RNA / oligonucleotidePhase 2
ARO-INHBE
RNA / oligonucleotidePhase 2
ARO-MAPT-SC
RNA / oligonucleotidePhase 2
ARO-RAGE
RNA / oligonucleotidePhase 2
ARV-806
Small moleculePhase 2
ASP546C
Antibody–drug conjugatePhase 2
AT-7687
PeptidePhase 2
ATH-063
Small moleculePhase 2
AU-007
Monoclonal antibodyPhase 2
AV078
Small moleculePhase 2
AVB-114
Cell therapyPhase 2
AVZO-021
Small moleculePhase 2
AVZO-023
Small moleculePhase 2
AVZO-1418
Small moleculePhase 2
AZD0171
Small moleculePhase 2
AZD0305
Antibody–drug conjugatePhase 2
AZD1163
Unknown / undisclosedPhase 2
AZD1775
Small moleculePhase 2No recent activity
AZD3427
Small moleculePhase 2
AZD3632
Unknown / undisclosedPhase 2
AZD4045
Cell therapyPhase 2
AZD4604
Unknown / undisclosedPhase 2
AZD5462
Small moleculePhase 2
AZD6234
PeptidePhase 2
AZD6750
Small moleculePhase 2
AZD7789
Multispecific antibodyPhase 2
AZD7798
Small moleculePhase 2
AZD8205
Antibody–drug conjugatePhase 2
AZD8630
Unknown / undisclosedPhase 2
AZD9550
PeptidePhase 2
Adipose-derived MSC clusters (S.Biomedics)
Cell therapyPhase 2
Afimetoran
Unknown / undisclosedPhase 2
Alintegimod
Small moleculePhase 2
Ametinib
Small moleculePhase 2
Anti-CD33 CAR T-cells
Unknown / undisclosedPhase 2
Apimostinel
Small moleculePhase 2
Arketamine (PRT042)
Small moleculePhase 2
B1962
Multispecific antibodyPhase 2
BA3071
Biologic — subtype unspecifiedPhase 2
BAT6026
Monoclonal antibodyPhase 2
BAY 3713372
Small moleculePhase 2
BAY3283142
Small moleculePhase 2
BBT-207
Small moleculePhase 2
BBT002
Multispecific antibodyPhase 2
BCMA CAR-NK (Hrain)
Cell therapyPhase 2
BCMA-CART (Bioray Laboratories)
Cell therapyPhase 2
BCMA-targeted Prime CAR-T cells (Chongqing Precision Biotech)
Cell therapyPhase 2
BDTX-1535
Small moleculePhase 2
BEBT-109
Small moleculePhase 2
BEBT-701
Biologic — subtype unspecifiedPhase 2
BEY2153
Small moleculePhase 2
BFB759
Monoclonal antibodyPhase 2
BG1805
Unknown / undisclosedPhase 2
BGB-11417
Unknown / undisclosedPhase 2
BGC101
Cell therapyPhase 2
BH-30643
Small moleculePhase 2
BI 1584862
Unknown / undisclosedPhase 2
BI 1815368
Unknown / undisclosedPhase 2
BI 3000202
Unknown / undisclosedPhase 2
BI 3032950
Monoclonal antibodyPhase 2
BI 3034701
PeptidePhase 2
BI 770371
Small moleculePhase 2
BI 771716
Antibody fragmentPhase 2
BI-1910
Monoclonal antibodyPhase 2
BIIB091
Unknown / undisclosedPhase 2
BIIB105
Unknown / undisclosedPhase 2
BL-M02D1
Small moleculePhase 2
BLEX 404
Small moleculePhase 2
BLU-924
Small moleculePhase 2
BMB-101
Small moleculePhase 2
BMF-219
Small moleculePhase 2
BMS-986158
Small moleculePhase 2
BMS-986435
Small moleculePhase 2
BMS-986446
Monoclonal antibodyPhase 2
BMS-986449
Small moleculePhase 2
BMS-986490
Small moleculePhase 2
BMS-986523
Small moleculePhase 2
BNT116
VaccinePhase 2
BNT324
Biologic — subtype unspecifiedPhase 2
BP1001
Unknown / undisclosedPhase 2
BPI-1178
Small moleculePhase 2
BPI-361175
Small moleculePhase 2
BPI-572270
Small moleculePhase 2
BPL-003 (mebufotenin benzoate)
Small moleculePhase 2
BSB-1001
Cell therapyPhase 2
BT5528
Small moleculePhase 2
BW-00112
RNA / oligonucleotidePhase 2
BW-20829
RNA / oligonucleotidePhase 2
Balstilimab
Monoclonal antibodyPhase 2
Beijing Biotech BCMA/CD19 dual-target CAR-T
Cell therapyPhase 2
Beijing Biotech BCMA/CD38 dual-target CAR-T
Cell therapyPhase 2
Beijing Biotech BCMA/GPRC5D dual-target CAR-T
Cell therapyPhase 2
Beijing Biotech anti-CD19 CAR-T
Unknown / undisclosedPhase 2
Bempikibart
Monoclonal antibodyPhase 2
Bepranemab
Monoclonal antibodyPhase 2
Bexmarilimab
Monoclonal antibodyPhase 2
BioTTT001
OtherPhase 2
Blinatumomab
Monoclonal antibodyPhase 2
Botensilimab
Monoclonal antibodyPhase 2
Bretisilocin
Small moleculePhase 2
CAB-AXL-ADC
Unknown / undisclosedPhase 2
CAB-ROR2-ADC
Unknown / undisclosedPhase 2
CAN04
Monoclonal antibodyPhase 2
CART84
Unknown / undisclosedPhase 2
CB03-154
Small moleculePhase 2
CCS1477
Unknown / undisclosedPhase 2
CCTx-001
Unknown / undisclosedPhase 2
CD123 targeted CAR-NK cells
Unknown / undisclosedPhase 2
CD123/CD33 CART
Unknown / undisclosedPhase 2
CDNF (cerebral dopamine neurotrophic factor)
Biologic — subtype unspecifiedPhase 2No recent activity
CDR132L
RNA / oligonucleotidePhase 2
CFI-400945
Unknown / undisclosedPhase 2
CIS-DPI
Small moleculePhase 2
CJRB-101
Small moleculePhase 2
CKD-506
Unknown / undisclosedPhase 2No recent activity
CKD-703
Small moleculePhase 2
CL-197
Small moleculePhase 2
CM313
Monoclonal antibodyPhase 2
CM326
Monoclonal antibodyPhase 2
CM512
Multispecific antibodyPhase 2
CNIC-Ferrer polypill · Trinomia
Small moleculePhase 2
CP-383
Small moleculePhase 2
CPL207280
Small moleculePhase 2No recent activity
CPL500036
Small moleculePhase 2
CRG-150
Cell therapyPhase 2
CS32582
Small moleculePhase 2
CSTI-500
Small moleculePhase 2
CT-996
Small moleculePhase 2
CT071
Cell therapyPhase 2
CTC-413
CombinationPhase 2
CTS2190
Small moleculePhase 2
CTX-712
Unknown / undisclosedPhase 2
CU01-1001
Small moleculePhase 2
CU104
Small moleculePhase 2
CX11
Small moleculePhase 2
Cannabidiol (Kanbis)
Small moleculePhase 2
Cariprazine long-acting injection (Mapi Pharma)
Small moleculePhase 2
Cemsidomide
Small moleculePhase 2
Corteria COR-1167
Small moleculePhase 2
Cusatuzumab
Monoclonal antibodyPhase 2
DA-2811
Small moleculePhase 2
DB-1305
Small moleculePhase 2
DB-1310
Small moleculePhase 2
DCP-001
Unknown / undisclosedPhase 2
DD01
PeptidePhase 2
DNV001
RNA / oligonucleotidePhase 2
DRP-104
Small moleculePhase 2
DS-3939a
Unknown / undisclosedPhase 2
DSP-1083
Cell therapyPhase 2
DSP107
Biologic — subtype unspecifiedPhase 2
DT-101
Small moleculePhase 2
DZD6008
Small moleculePhase 2
Debio 0123
Small moleculePhase 2
Debio 1562M
Unknown / undisclosedPhase 2
Decoy20
Small moleculePhase 2
Diranersen
RNA / oligonucleotidePhase 2
Dositinib mesylate
Small moleculePhase 2
Dual-target Car-nk Cells
Cell therapyPhase 2
EB-SELECT Dual-Target CAR-NK Cells
Cell therapyPhase 2
EB-SELECT Single-Target CAR-NK Cells
Cell therapyPhase 2
EC5026
Small moleculePhase 2
ECI830
Small moleculePhase 2
EDP167
RNA / oligonucleotidePhase 2
ELE-101 · ELE-101
Small moleculePhase 2
EMB-01
Multispecific antibodyPhase 2
EMP16
Small moleculePhase 2
ENERGI-F705
Small moleculePhase 2
ENV-294
Small moleculePhase 2
ENV-501
Antibody–drug conjugatePhase 2
EP0031
Small moleculePhase 2
EP0042
Unknown / undisclosedPhase 2
EP0062
Small moleculePhase 2
ERX1000
Small moleculePhase 2
ES102
Small moleculePhase 2
ETX101
Gene therapy / editingPhase 2
EVO301
Protein / enzyme therapeuticPhase 2
EVO756
Small moleculePhase 2
EcoActive
Microbiome therapeuticPhase 2
Eganelisib
Unknown / undisclosedPhase 2
Elironrasib
Small moleculePhase 2
Eltanexor
Unknown / undisclosedPhase 2
Elunetirom
Small moleculePhase 2
Emavusertib
Unknown / undisclosedPhase 2
Enfortumab Vedotin
Antibody–drug conjugatePhase 2
Enrupatinib
Small moleculePhase 2
Enzomenib
Small moleculePhase 2
Etribnabdione
Unknown / undisclosedPhase 2
Evexomostat
Unknown / undisclosedPhase 2
Evorpacept
Protein / enzyme therapeuticPhase 2
ExoFlo
Cell therapyPhase 2
FB825
Monoclonal antibodyPhase 2
FCN-338
Small moleculePhase 2
FF-10832
Small moleculePhase 2
FMC-376
Small moleculePhase 2
FT819
Unknown / undisclosedPhase 2
FWD1802
Small moleculePhase 2
Fc-relaxin fusion protein (TX45)
Protein / enzyme therapeuticPhase 2
Forimtamig
Multispecific antibodyPhase 2
GC101
Cell therapyPhase 2
GEN-725
Small moleculePhase 2
GEN1042
Biologic — subtype unspecifiedPhase 2
GFH276
Small moleculePhase 2
GH21
Small moleculePhase 2
GHZ339
Biologic — subtype unspecifiedPhase 2
GI-101
Small moleculePhase 2
GI-101A
Small moleculePhase 2
GI-108
Multispecific antibodyPhase 2
GIA632
Biologic — subtype unspecifiedPhase 2
GIC-102
Cell therapyPhase 2
GK1-399 (formerly TTP399)
Small moleculePhase 2No recent activity
GL0034
PeptidePhase 2
GM-XANTHO
BotanicalPhase 2
GPC-100
Small moleculePhase 2
GRWD5769
Small moleculePhase 2
GSK2857914
Monoclonal antibodyPhase 2
GSK4527226 (AL101)
Monoclonal antibodyPhase 2
GSK4532990
Unknown / undisclosedPhase 2
GSK5784283
Monoclonal antibodyPhase 2
GT-02287
Small moleculePhase 2
GUB-UCN2
PeptidePhase 2
GV20-0251
Monoclonal antibodyPhase 2
GVV858
Unknown / undisclosedPhase 2
GW117
Small moleculePhase 2
GXV813
Small moleculePhase 2
GZR101
PeptidePhase 2
GlyphAllo (allopregnanolone prodrug) · SPT-300
Small moleculePhase 2
H002
Small moleculePhase 2
HB0036
Multispecific antibodyPhase 2
HBI-002
Small moleculePhase 2
HC010
Multispecific antibodyPhase 2
HEC169096
Small moleculePhase 2
HL-1186
Small moleculePhase 2
HL-300
Small moleculePhase 2
HLX208
Small moleculePhase 2
HLX208 + HLX10
CombinationPhase 2
HLX26
Monoclonal antibodyPhase 2
HLX301
Multispecific antibodyPhase 2
HM15275
PeptidePhase 2
HMBD-001
Monoclonal antibodyPhase 2
HRC0202
Cell therapyPhase 2
HRS-1301
Small moleculePhase 2
HRS-4508
Antibody–drug conjugatePhase 2
HRS-4729
PeptidePhase 2
HRS-5346
Small moleculePhase 2
HRS-5632
Unknown / undisclosedPhase 2
HRS-6209
Small moleculePhase 2
HRS-7085
Small moleculePhase 2
HRS-7249
Unknown / undisclosedPhase 2
HRS-9057
Small moleculePhase 2
HRS-9563
RNA / oligonucleotidePhase 2
HRS-9821
Small moleculePhase 2
HS-001
Cell therapyPhase 2
HS-10353
Small moleculePhase 2
HS-10380
Small moleculePhase 2
HS-10390
Small moleculePhase 2
HSG4112
Small moleculePhase 2No recent activity
HSK44459
Small moleculePhase 2
HSK47388
Small moleculePhase 2
HT-4253
Small moleculePhase 2
HTI vaccine (ChAdOx1.HTI/MVA.HTI)
VaccinePhase 2
HU6
Small moleculePhase 2
HY209gel
Small moleculePhase 2
HYP-6589
Small moleculePhase 2
Hank
Cell therapyPhase 2
Hebei Senlang CD7 CAR-T
Cell therapyPhase 2
Hemay007
Small moleculePhase 2No recent activity
Hrain anti-BCMA CAR-T
Cell therapyPhase 2
HuL001
Monoclonal antibodyPhase 2
HucMSC intramyocardial therapy
Cell therapyPhase 2
Human Acellular Vessel (Humacyte)
OtherPhase 2
Hypidone (YL-0919)
Small moleculePhase 2No recent activity
IAP0971
Small moleculePhase 2
IBI3016
RNA / oligonucleotidePhase 2
IBI356
Monoclonal antibodyPhase 2
IBI363
Multispecific antibodyPhase 2
ICG318
Cell therapyPhase 2
ICP-490
Small moleculePhase 2
IDE397
Small moleculePhase 2
IDP-001
Small moleculePhase 2
IDP-023
Cell therapyPhase 2
IDP-121
Small moleculePhase 2
ILKN421H
Small moleculePhase 2
IMG-007
Monoclonal antibodyPhase 2
IMM-1-104
Small moleculePhase 2
IMM2510
Small moleculePhase 2
IMT-009
Monoclonal antibodyPhase 2
IN-115314
Small moleculePhase 2
INBRX-106
Small moleculePhase 2
INV-202
Small moleculePhase 2
INV-6452
Small moleculePhase 2
INV-8989
Small moleculePhase 2
IOA-244
Small moleculePhase 2
ION337
RNA / oligonucleotidePhase 2
ION775
RNA / oligonucleotidePhase 2
ION904
RNA / oligonucleotidePhase 2No recent activity
IOV-4001
Biologic — subtype unspecifiedPhase 2
IP-001
Small moleculePhase 2
IPG11406
Small moleculePhase 2
IRL757
Small moleculePhase 2
IRX4204
Small moleculePhase 2
ITI-1284
Small moleculePhase 2
Icalcaprant
Small moleculePhase 2
Ifinatamab Deruxtecan
Biologic — subtype unspecifiedPhase 2
Imatinib mesylate prodrug (IkT-001Pro)
Small moleculePhase 2
ImmuneOnco anti-PAH candidate (IMC-003)
Biologic — subtype unspecifiedPhase 2
Imzokitug
Monoclonal antibodyPhase 2
Inaxaplin
Small moleculePhase 2
Inebilizumab
Monoclonal antibodyPhase 2
Interferon-beta1
Unknown / undisclosedPhase 2
Iopofosine I-131
RadiopharmaceuticalPhase 2
JAB-23E73
Small moleculePhase 2
JAB-8263
Small moleculePhase 2
JIN-A02
Small moleculePhase 2
JK07
Biologic — subtype unspecifiedPhase 2
JK08
Monoclonal antibodyPhase 2
JL18008
Protein / enzyme therapeuticPhase 2
JMKX000623
Small moleculePhase 2
JMT202
Unknown / undisclosedPhase 2
JNJ-42756493
Small moleculePhase 2
JNJ-64042056
VaccinePhase 2
JNJ-89495120
Small moleculePhase 2
JNJ-95597528
Unknown / undisclosedPhase 2
JS111 AP-L1898
Small moleculePhase 2
JS207
Multispecific antibodyPhase 2
JS212
Multispecific antibodyPhase 2
JTT-861
Small moleculePhase 2
JX11502MA
Small moleculePhase 2No recent activity
JYP0015
Small moleculePhase 2
JYP0061
Small moleculePhase 2
Jia Shen Tablet
BotanicalPhase 2
KB707
Biologic — subtype unspecifiedPhase 2
KDS2010
Small moleculePhase 2
KIT2014
PeptidePhase 2
KL-A167
Small moleculePhase 2
KL590586
Small moleculePhase 2
KM-819
Small moleculePhase 2
KQ-2003
Cell therapyPhase 2
KSP-0243
Small moleculePhase 2
KT-621
Small moleculePhase 2
Kylo-11
Small moleculePhase 2
L-DOS47
Monoclonal antibodyPhase 2No recent activity
LAM-001
Small moleculePhase 2
LB54640
PeptidePhase 2
LBL-024
Small moleculePhase 2
LBL-034
Unknown / undisclosedPhase 2
LCB84
Monoclonal antibodyPhase 2
LHP588
Small moleculePhase 2
LM103
Cell therapyPhase 2
LM11A-31
Small moleculePhase 2No recent activity
LN-145
Cell therapyPhase 2
LN-145-S1
Unknown / undisclosedPhase 2
LNK01004
Small moleculePhase 2
LNS8801
Small moleculePhase 2
LP-184
Small moleculePhase 2
LP-98
PeptidePhase 2
LS301-IT
Small moleculePhase 2
LT-002-158
Small moleculePhase 2
LV232
Small moleculePhase 2
LX1001
Gene therapy / editingPhase 2
LY03020
Small moleculePhase 2
LY4065967
Small moleculePhase 2
Laromestrocel · Lomecel-B
Cell therapyPhase 2
Lenrispodun (ITI-214)
Small moleculePhase 2
Lipovirtide
PeptidePhase 2
Live SK08
Microbiome therapeuticPhase 2
Lu AF28996
Small moleculePhase 2
Luvometinib
Unknown / undisclosedPhase 2
M701
Multispecific antibodyPhase 2
MAR001
Monoclonal antibodyPhase 2
MB-001
Monoclonal antibodyPhase 2
MBS314
Unknown / undisclosedPhase 2
MCLA-129
Multispecific antibodyPhase 2
MDNA11
Small moleculePhase 2
MET-233i
PeptidePhase 2
MK-2214
Monoclonal antibodyPhase 2
MK-8690
Biologic — subtype unspecifiedPhase 2
ML-007C-MA
Small moleculePhase 2
MN-001
Unknown / undisclosedPhase 2
MP0533
Multispecific antibodyPhase 2
MRT-2359
Small moleculePhase 2
MRX-2843
Small moleculePhase 2
MT-201
Multispecific antibodyPhase 2
MT-501
Small moleculePhase 2
MT101-5
Small moleculePhase 2
MZE829
Small moleculePhase 2
Matsupexole (KDT-3594)
Small moleculePhase 2
Mebufotenin (5-MeO-DMT) · GH001
Small moleculePhase 2
Melevodopa/carbidopa (Sirio) · Sirio
Small moleculePhase 2No recent activity
Menstrual blood-derived mesenchymal stem cells (MenSCs)
Cell therapyPhase 2No recent activity
Mesenchymal Precursor Cells (MPCs)
Cell therapyPhase 2No recent activity
Mevidalen
Small moleculePhase 2
Mirivadelgat
Small moleculePhase 2
Mivelsiran
RNA / oligonucleotidePhase 2
Mosedipimod
Small moleculePhase 2
Mosliciguat
Small moleculePhase 2
N17350
Biologic — subtype unspecifiedPhase 2
NA-931
Small moleculePhase 2
NBI-1117570
Small moleculePhase 2
NBTXR3
Small moleculePhase 2
NDI-101150
Small moleculePhase 2
NEO212
Small moleculePhase 2
NEU-411
Small moleculePhase 2
NGM707
Unknown / undisclosedPhase 2
NH102
Small moleculePhase 2
NNC0519-0130
PeptidePhase 2
NNC0662-0419
PeptidePhase 2
NPT2042
Small moleculePhase 2
NRD135S.E1
Small moleculePhase 2
NSC001
Small moleculePhase 2
NT-0796
Small moleculePhase 2
NTRX-07
Small moleculePhase 2
NX-13
Small moleculePhase 2
Namodenoson
Unknown / undisclosedPhase 2
NanoLithium NP03
Small moleculePhase 2
Natrunix
Unknown / undisclosedPhase 2
Nelivaptan
Small moleculePhase 2No recent activity
Nelmastobart
Small moleculePhase 2
Ninerafaxstat · IMB-101
Small moleculePhase 2
Nirogacestat
Small moleculePhase 2
NouvNeu001
Cell therapyPhase 2
OBI-833
Biologic — subtype unspecifiedPhase 2
OBX-115
Biologic — subtype unspecifiedPhase 2
OD-07656
Small moleculePhase 2
ODX (Osteodex)
Unknown / undisclosedPhase 2
ONO-1110
Small moleculePhase 2
ONO-2020
Small moleculePhase 2
OPC-415
Cell therapyPhase 2
OPK-88006
Unknown / undisclosedPhase 2
OR502
Monoclonal antibodyPhase 2
ORIC-114
Small moleculePhase 2
ORKA-001
Monoclonal antibodyPhase 2
ORKA-002
Monoclonal antibodyPhase 2
OSE-279
VaccinePhase 2
Olverembatinib
Unknown / undisclosedPhase 2
Olvimulogene nanivacirepvec
OtherPhase 2
OpSCF
Monoclonal antibodyPhase 2
OriCAR-017
Cell therapyPhase 2
Orticumab
Monoclonal antibodyPhase 2
Oxylanthanum carbonate
Small moleculePhase 2
PB-718
PeptidePhase 2
PBF-680
Unknown / undisclosedPhase 2No recent activity
PF-04634817
Unknown / undisclosedPhase 2No recent activity
PF-07328948
Small moleculePhase 2
PF-07868489
Protein / enzyme therapeuticPhase 2
PF-08049820
Small moleculePhase 2
PG-102
PeptidePhase 2
PH-10
Small moleculePhase 2No recent activity
PH009-1
Small moleculePhase 2
PHE885
Cell therapyPhase 2
PL8177
PeptidePhase 2
PR001 (LY3884961)
Gene therapy / editingPhase 2
PRAX-222
RNA / oligonucleotidePhase 2
PRI-002
Small moleculePhase 2
PT-112
Small moleculePhase 2No recent activity
PT199
Monoclonal antibodyPhase 2
PT320
Small moleculePhase 2No recent activity
PVX-410
PeptidePhase 2
Pamlectabart tismanitin
OtherPhase 2
Pegenzileukin
Protein / enzyme therapeuticPhase 2
Pepinemab
Monoclonal antibodyPhase 2
Pirenzepine (topical)
Small moleculePhase 2
PolyCore
OtherPhase 2
Praliciguat
Small moleculePhase 2
Purinostat Mesylate
Small moleculePhase 2
QLS12010
Small moleculePhase 2
QLS1304
Small moleculePhase 2
QLS1410
Small moleculePhase 2
QLS4131
Multispecific antibodyPhase 2
QLS5132
Unknown / undisclosedPhase 2
QiShenYiQi
BotanicalPhase 2
Quaratusugene Ozeplasmid
Gene therapy / editingPhase 2
R2R01
Biologic — subtype unspecifiedPhase 2
RAPA-201
Cell therapyPhase 2
RB-ADSC
Cell therapyPhase 2
RBD5044
RNA / oligonucleotidePhase 2
RC108
Antibody–drug conjugatePhase 2
RC1416
Multispecific antibodyPhase 2
RD01 (PEG-EPO)
Biologic — subtype unspecifiedPhase 2No recent activity
REGEND001
Cell therapyPhase 2
REGN13335
Monoclonal antibodyPhase 2
REGN17372
Multispecific antibodyPhase 2
REGN5093
Small moleculePhase 2
REGN5459
Multispecific antibodyPhase 2
REGN7075
Multispecific antibodyPhase 2
REGN7945
Multispecific antibodyPhase 2
RLS-0071
PeptidePhase 2
RM-718
PeptidePhase 2
RMC-9805
Small moleculePhase 2
RN0361
RNA / oligonucleotidePhase 2
RNDP-001
Cell therapyPhase 2
RO7204239
PeptidePhase 2
RO7247669
Small moleculePhase 2
RO7269162
Monoclonal antibodyPhase 2
ROC-101
Small moleculePhase 2
RP1
Biologic — subtype unspecifiedPhase 2
RP902
Small moleculePhase 2
RSS0343
Small moleculePhase 2
RTN-001
Small moleculePhase 2
RVU120
Unknown / undisclosedPhase 2
RYZ101
RadiopharmaceuticalPhase 2
Raludotatug Deruxtecan
Biologic — subtype unspecifiedPhase 2
Ravagalimab
Monoclonal antibodyPhase 2
Rina-S
Small moleculePhase 2
Ropanicant
Small moleculePhase 2
Rosnilimab
Monoclonal antibodyPhase 2
S230815
RNA / oligonucleotidePhase 2
S241656
Small moleculePhase 2
S243249
Unknown / undisclosedPhase 2
SAL0120
Small moleculePhase 2
SAL0137
Small moleculePhase 2
SAL0140
Small moleculePhase 2
SAR402663
Gene therapy / editingPhase 2
SAR422459
Unknown / undisclosedPhase 2
SAR439459
Biologic — subtype unspecifiedPhase 2
SAR443579
Unknown / undisclosedPhase 2
SAR446597
Gene therapy / editingPhase 2
SAR448851
Unknown / undisclosedPhase 2
SC0062
Small moleculePhase 2
SCM-AGH
Cell therapyPhase 2No recent activity
SEFA-1024
Small moleculePhase 2
SENL103
Cell therapyPhase 2
SER-100
Small moleculePhase 2No recent activity
SG2918
Biologic — subtype unspecifiedPhase 2
SHR-1139
Monoclonal antibodyPhase 2
SHR-3167
Small moleculePhase 2
SHR-6209
Small moleculePhase 2
SHR-A1921
Small moleculePhase 2
SHR-A2102
Antibody–drug conjugatePhase 2
SHR2554
Small moleculePhase 2
SHR6508
Small moleculePhase 2
SI-B003
Multispecific antibodyPhase 2
SKB571 For
Antibody–drug conjugatePhase 2
SL-28
Biologic — subtype unspecifiedPhase 2
SLS-002 · SLS-002
Small moleculePhase 2No recent activity
SLS009
Small moleculePhase 2
SM17
Monoclonal antibodyPhase 2
SMS001
Small moleculePhase 2
SNK01
Cell therapyPhase 2
SNS-101
Monoclonal antibodyPhase 2
SPG302
Small moleculePhase 2
SPN-817
Small moleculePhase 2
SPN-821
Small moleculePhase 2
SPY001
Monoclonal antibodyPhase 2
SPY002
Monoclonal antibodyPhase 2
SPY002-072
Unknown / undisclosedPhase 2
SPY003
Monoclonal antibodyPhase 2
SRSD107
RNA / oligonucleotidePhase 2
SRSD216
RNA / oligonucleotidePhase 2
SSGJ-706
Multispecific antibodyPhase 2
SSS17
Small moleculePhase 2
ST-067
Biologic — subtype unspecifiedPhase 2
STAR0602
Small moleculePhase 2
STI-6129
Antibody–drug conjugatePhase 2
STK-001
RNA / oligonucleotidePhase 2
STK-012
Small moleculePhase 2
STMC-103H
Microbiome therapeuticPhase 2
STX-241
Small moleculePhase 2
STX-721
Small moleculePhase 2
SUL-238
Small moleculePhase 2
SY-004
Small moleculePhase 2No recent activity
SY-009
Small moleculePhase 2
SYH2068
RNA / oligonucleotidePhase 2
SYH2070
RNA / oligonucleotidePhase 2
SYS6090
Small moleculePhase 2
Sabirnetug
Monoclonal antibodyPhase 2
Samuraciclib
Small moleculePhase 2
Saroglitazar · Lipaglyn
Small moleculePhase 2
Selnoflast
Small moleculePhase 2
Semzuvolimab
Monoclonal antibodyPhase 2
Serabelisib
Small moleculePhase 2
Stempeucel · Stempeucel
Cell therapyPhase 2
Surzetoclax
Small moleculePhase 2
Sutetinib
Small moleculePhase 2
T3011
Monoclonal antibodyPhase 2
TAS0953
Small moleculePhase 2
TB006
Biologic — subtype unspecifiedPhase 2
TB511
PeptidePhase 2
TCC1727
Small moleculePhase 2
TDM-180935
Small moleculePhase 2
TED-A9 (A9-DPC)
Cell therapyPhase 2
TGRX-814
Unknown / undisclosedPhase 2
TH9619
Small moleculePhase 2
THDBH120
PeptidePhase 2
TLC-2716
Small moleculePhase 2
TMB-365 / TMB-380
CombinationPhase 2
TML-6
Small moleculePhase 2
TNG260
Small moleculePhase 2
TNG456
Small moleculePhase 2
TNG462
Small moleculePhase 2
TQC3927
Small moleculePhase 2
TQH2929
Monoclonal antibodyPhase 2
TR-012001
Small moleculePhase 2
TRIV-509
Monoclonal antibodyPhase 2
TRX103
Cell therapyPhase 2
TSN1611
Small moleculePhase 2
TT-10
Small moleculePhase 2
TT-4
Small moleculePhase 2
TTP273
Small moleculePhase 2No recent activity
TTYP01
Small moleculePhase 2
TUB-030
Small moleculePhase 2
TUB-040
Small moleculePhase 2
Talineuren
Biologic — subtype unspecifiedPhase 2
Tinengotinib
Small moleculePhase 2
Tofogliflozin · Apleway / Deberza
Small moleculePhase 2
Tonlamarsen
RNA / oligonucleotidePhase 2
Tovinontrine
Small moleculePhase 2
Traneurocin
Small moleculePhase 2No recent activity
Trosunilimab
Monoclonal antibodyPhase 2
Trovocabtagene autoleucel (C-CAR088)
Cell therapyPhase 2
Tuspetinib
Small moleculePhase 2
U32 CAR-T
Unknown / undisclosedPhase 2
UCB0022
Small moleculePhase 2
UMC119-06
Cell therapyPhase 2
UX-DA003
Cell therapyPhase 2
Ubamatamab
Monoclonal antibodyPhase 2
VENT-02
Small moleculePhase 2
VENT-03
Unknown / undisclosedPhase 2
VERT-002
Small moleculePhase 2
VGN-R08b
Gene therapy / editingPhase 2
VGN-R09b
Gene therapy / editingPhase 2
VH3739937
Small moleculePhase 2
VHB937
Monoclonal antibodyPhase 2
VK2809
Small moleculePhase 2
VLS-01
Small moleculePhase 2
VLS-1488
Small moleculePhase 2
VMD-102
Small moleculePhase 2
VMD-928
Small moleculePhase 2
VRB-101
PeptidePhase 2
VRN110755
Small moleculePhase 2
VS-7375
Small moleculePhase 2
VSV-IFNβ-NIS
OtherPhase 2
VT3989
Small moleculePhase 2
VTX3232
Small moleculePhase 2
VV119
Small moleculePhase 2
VX-993
Small moleculePhase 2
VY7523
Monoclonal antibodyPhase 2
Vicagrel
Unknown / undisclosedPhase 2
Visugromab
Monoclonal antibodyPhase 2
Vutiglabridin
Small moleculePhase 2
WD-1603
Small moleculePhase 2No recent activity
WEF-001
Small moleculePhase 2
WIN378
Monoclonal antibodyPhase 2
WVE-007
RNA / oligonucleotidePhase 2
XEN-D0501
Small moleculePhase 2No recent activity
XJN010
Small moleculePhase 2
XKH001
Monoclonal antibodyPhase 2
XS-411
Cell therapyPhase 2
XTR003
OtherPhase 2
XTX501
Small moleculePhase 2
XYA02
Antibody–drug conjugatePhase 2
XZP-5955
Small moleculePhase 2
XmAb942
Monoclonal antibodyPhase 2
YH32364
Small moleculePhase 2
YH42946
Small moleculePhase 2
YKST02
Multispecific antibodyPhase 2
YL201
Small moleculePhase 2
YN001
Protein / enzyme therapeuticPhase 2
ZG005
Biologic — subtype unspecifiedPhase 2
ZL-1102
Monoclonal antibodyPhase 2
ZL-82
Small moleculePhase 2
ZT002
PeptidePhase 2
ZT006
PeptidePhase 2
Zelenectide pevedotin
Small moleculePhase 2
Zhibitai · Zhibitai
Small moleculePhase 2
Zibotentan + Dapagliflozin
Small moleculePhase 2
Zoldonrasib
Small moleculePhase 2
Zorifertinib
Small moleculePhase 2
Zumilokibart
Monoclonal antibodyPhase 2
alvelestat
Small moleculePhase 2
amiselimod
Small moleculePhase 2
apitegromab
Monoclonal antibodyPhase 2
atamparib
Small moleculePhase 2
barzolvolimab
Monoclonal antibodyPhase 2
bivamelagon
Small moleculePhase 2
camoteskimab
Monoclonal antibodyPhase 2
clofutriben
Small moleculePhase 2
cyclobenzaprine · Tonmya
Small moleculePhase 2
dapiglutide
PeptidePhase 2
deramiocel · CAP-1002
Cell therapyPhase 2No recent activity
enobosarm
Small moleculePhase 2
exidavnemab
Monoclonal antibodyPhase 2
fludarabine/cyclophosphamide
Unknown / undisclosedPhase 2
galvokimig
Multispecific antibodyPhase 2
garetosmab
Monoclonal antibodyPhase 2
garutadustat
Small moleculePhase 2
glasmacinal
Small moleculePhase 2
hepalatide
PeptidePhase 2
itraconazole
Unknown / undisclosedPhase 2
lumacaftor
Small moleculePhase 2
lutikizumab
Monoclonal antibodyPhase 2
mRNA-2808
RNA / oligonucleotidePhase 2
macupatide
PeptidePhase 2
nanosomal tacrolimus
Small moleculePhase 2
nimacimab
Monoclonal antibodyPhase 2
olamkicept
Protein / enzyme therapeuticPhase 2No recent activity
olatorepatide
PeptidePhase 2
ompekimig
Multispecific antibodyPhase 2
pemvidutide
PeptidePhase 2
petrelintide
PeptidePhase 2
regor GLP-1
Small moleculePhase 2
rezatapopt
Small moleculePhase 2
roginolisib
Small moleculePhase 2
soquelitinib
Small moleculePhase 2
taldefgrobep alfa
Antibody-derived scaffoldPhase 2
tamuzimod
Small moleculePhase 2
tesofensine
Small moleculePhase 2No recent activity
trevogrumab
Monoclonal antibodyPhase 2
verekitug
Monoclonal antibodyPhase 2
zabalafin
Small moleculePhase 2